January 13, 2023

QT Imaging to Present at the 3rd Annual B. Riley Securities Oncology Conference

QT Imaging to Present at the 3rd Annual B. Riley Securities Oncology Conference

Novato, CA – January 13, 2023 – QT Imaging, Inc., a medical imaging company focused on the development and clinical adoption of novel products for breast cancer imaging (“QT Imaging”), today announced participation of John Klock, MD, Chief Executive Officer, in the Third Annual B. Riley Securities Oncology Conference, on January 18th and 19th. The event will feature one-on-one discussions, fireside chats, and presentations regarding cancer treatment, testing, and monitoring modalities with public and private healthcare companies.
The live and archived webcast of the presentation will be accessible from the company’s website at https://qtimaging.com/events-presentations. The replay of the webcast will be available for 30 days.

About QT Imaging
QT Imaging is a vertically integrated medical imaging company in the business of manufacturing ultra-low frequency transmitted sound imaging systems for breast and body imaging. QT Imaging’s FDA-cleared breast scanner is deployed in three US and two foreign locations. QT Imaging is entering a commercial growth phase and is in final stages of combining with GigCapital5, Inc. (“GigCapital5”) (NYSE: GIA.U; GIA; GIA.WS) to go public in the first half of 2023. The GigCapital5 joint Proxy Statement/prospectus and the Registration Statement in which these are contained, and other reports can be obtained, without charge, at the SEC’s web site (http://www.sec.gov). QT Imaging would use the proceeds of the merger to further expand its commercial activities.